| Serial Number | 97896516 |
| Word Mark | BYNUCMA |
| Filing Date | Wednesday, April 19, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, July 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 15, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Event Date | Event Description |
| Monday, May 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, April 22, 2023 | NEW APPLICATION ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, August 9, 2023 | ASSIGNED TO EXAMINER |
| Thursday, August 10, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, August 10, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, August 10, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 9, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, July 25, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 25, 2024 | SOU EXTENSION 1 FILED |
| Thursday, July 25, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |